Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by MirrorWorldManon Dec 03, 2021 6:31pm
121 Views
Post# 34197131

RE:RE:Wangbang phase 1

RE:RE:Wangbang phase 1Howie has not been able to license the molecule to anyone else for phase testing and Wanbang took eight years to get nowhere with it.   Generics can arise 20 years post patent and we have already lost 8 of those 20 years. On top of that it  years and millions of dollars to establish endpoint trials trials to make it even remotely possible to be used by any sensible doctor that does not want to be sued. So it takes about 7 years on average to do Phase 1-3 trials and we don't even have published  results from WannaBang for phae 1 yet. The SGLT2  is almost worthless now. Howie screwed up with. He must quit and go be a doctor. It is unacceptable to lose such a valuable asset, he would of been fired long ago from any reputable company 
<< Previous
Bullboard Posts
Next >>